These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25792823)

  • 1. Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats.
    Valiante S; Falanga A; Cigliano L; Iachetta G; Busiello RA; La Marca V; Galdiero M; Lombardi A; Galdiero S
    Int J Nanomedicine; 2015; 10():1885-98. PubMed ID: 25792823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced uptake of gH625 by blood brain barrier compared to liver in vivo: characterization of the mechanism by an in vitro model and implications for delivery.
    Falanga A; Iachetta G; Lombardi L; Perillo E; Lombardi A; Morelli G; Valiante S; Galdiero S
    Sci Rep; 2018 Sep; 8(1):13836. PubMed ID: 30218088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery.
    Iachetta G; Falanga A; Molino Y; Masse M; Jabès F; Mechioukhi Y; Laforgia V; Khrestchatisky M; Galdiero S; Valiante S
    Sci Rep; 2019 Jun; 9(1):9183. PubMed ID: 31235716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shuttle-mediated nanoparticle delivery to the blood-brain barrier.
    Guarnieri D; Falanga A; Muscetti O; Tarallo R; Fusco S; Galdiero M; Galdiero S; Netti PA
    Small; 2013 Mar; 9(6):853-62. PubMed ID: 23135878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery.
    Tarallo R; Accardo A; Falanga A; Guarnieri D; Vitiello G; Netti P; D'Errico G; Morelli G; Galdiero S
    Chemistry; 2011 Nov; 17(45):12659-68. PubMed ID: 21956538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins.
    Smaldone G; Falanga A; Capasso D; Guarnieri D; Correale S; Galdiero M; Netti PA; Zollo M; Galdiero S; Di Gaetano S; Pedone E
    Int J Nanomedicine; 2013; 8():2555-65. PubMed ID: 23901273
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Galdiero E; Falanga A; Siciliano A; Maselli V; Guida M; Carotenuto R; Tussellino M; Lombardi L; Benvenuto G; Galdiero S
    Int J Nanomedicine; 2017; 12():2717-2731. PubMed ID: 28435254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shuttle-mediated nanoparticle transport across an in vitro brain endothelium under flow conditions.
    Falanga AP; Pitingolo G; Celentano M; Cosentino A; Melone P; Vecchione R; Guarnieri D; Netti PA
    Biotechnol Bioeng; 2017 May; 114(5):1087-1095. PubMed ID: 27861732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines.
    Perillo E; Porto S; Falanga A; Zappavigna S; Stiuso P; Tirino V; Desiderio V; Papaccio G; Galdiero M; Giordano A; Galdiero S; Caraglia M
    Oncotarget; 2016 Jan; 7(4):4077-92. PubMed ID: 26554306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimers.
    Falanga A; Tarallo R; Carberry T; Galdiero M; Weck M; Galdiero S
    PLoS One; 2014; 9(11):e112128. PubMed ID: 25423477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells.
    Perillo E; Allard-Vannier E; Falanga A; Stiuso P; Vitiello MT; Galdiero M; Galdiero S; Chourpa I
    Int J Pharm; 2015 Jul; 488(1-2):59-66. PubMed ID: 25891256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically synthesized peptide libraries as a new source of BBB shuttles. Use of mass spectrometry for peptide identification.
    Guixer B; Arroyo X; Belda I; Sabidó E; Teixidó M; Giralt E
    J Pept Sci; 2016 Sep; 22(9):577-91. PubMed ID: 27440580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles.
    Malakoutikhah M; Prades R; Teixidó M; Giralt E
    J Med Chem; 2010 Mar; 53(6):2354-63. PubMed ID: 20170117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
    Tam VH; Sosa C; Liu R; Yao N; Priestley RD
    Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gH625: a milestone in understanding the many roles of membranotropic peptides.
    Galdiero S; Falanga A; Morelli G; Galdiero M
    Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):16-25. PubMed ID: 25305339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and orientation of the gH625-644 membrane interacting region of herpes simplex virus type 1 in a membrane mimetic system.
    Galdiero S; Russo L; Falanga A; Cantisani M; Vitiello M; Fattorusso R; Malgieri G; Galdiero M; Isernia C
    Biochemistry; 2012 Apr; 51(14):3121-8. PubMed ID: 22397737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimerization in tailoring uptake efficacy of the HSV-1 derived membranotropic peptide gH625.
    Falanga A; Valiante S; Galdiero E; Franci G; Scudiero O; Morelli G; Galdiero S
    Sci Rep; 2017 Aug; 7(1):9434. PubMed ID: 28842580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanofiber-based delivery of therapeutic peptides to the brain.
    Mazza M; Notman R; Anwar J; Rodger A; Hicks M; Parkinson G; McCarthy D; Daviter T; Moger J; Garrett N; Mead T; Briggs M; Schätzlein AG; Uchegbu IF
    ACS Nano; 2013 Feb; 7(2):1016-26. PubMed ID: 23289352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
    Pardridge WM
    Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.